Summary
Metyrapone [2-methyl-1,2-bis-(3-pyridyl)-1-propanone] in a concentration of 5 mM increased the lactate/pyruvate ratio and theΒ-hydroxybutyrate/ acetoacetate ratio in the perfusion fluid of the isolated rat liver by a factor of 6 indicating a considerable shift in the ratio of free [NAD]/[NADH] in both the cytoplasmic and the mitochondrial compartment. Oxygen uptake of the isolated liver was decreased to about one half. The onset of the inhibitory effect on the respiration of the isolated organ was immediate. The inhibition lasted for at least 1 h.
In experiments with isolated mitochondria utilizingΒ-hydroxybutyrate as a substrate, a decrease of the respiration rate and of the rate of ferricyanide reduction to about one half was observed after the addition of 5 mM metyrapone. Thein vitro findings indicate that the effect of metyrapone on the metabolic state of the isolated organ is due to an attack by the substance on the respiratory chain. The entrance of hydrogen into the chain mediated byΒ-hydroxybutyrate dehydrogenase as well as the terminal oxidation in the chain were not affected by metyrapone.
Similar content being viewed by others
References
Bücher, Th., Klingenberg, M.: Wege des Wasserstoffs in der lebendigen Organisation. Angew. Chem.70, 552 (1958).
—, Rüssmann, W.: Equilibrium and nonequilibrium in the glycolysis system. Aagew. Chem.75, 881 (1963).
Dean, P. D. G., Whitehouse, M. W.: The effects of metyrapone (Su 4885) and some hypercholesterolaemic drugs on hepatic sterol and fatty acid oxidation. Biochem. Pharmacol.16, 441 (1967).
Dixon, M.: The determination of enzyme inhibitor constants. Biochem. J.55, 170 (1953).
Erickson, R. E., Ertel, R. J., Ungar, F.: Effect of Su-4885 on steroid 18-hydroxylation in the mouse adrenal in vitro. Endocrinology78, 343 (1966).
Estabrook, R. W.: Studies of oxidative phosphorylation with potassium ferricyanide as electron acceptor. J. biol. Chem.236, 3051 (1961).
Gaunt, R., Chart, J. J., Renzi, A. A.: Inhibitors of adrenal cortical function. Ergebn. Physiol.56, 114 (1965).
Hems, R., Ross, B. D., Berry, M. N., Krebs, H. A.: Gluconeogenesis in the perfused rat liver. Biochem. J.101, 284 (1966).
Hildebrandt, A. G., Leibman, K. C., Estabrook, R. W.: Metyrapone interaction with hepatic microsomal cytochrome P-450 from rats treated with phenobarbital. Biochem. biophys. Res. Commun.37, 477 (1969).
Hofmann, P., Wollert, U.: über die subcellulÄre Verteilung von 3,3′-Dimethyl4,4′-diacetyldiphenylbisguanylhydrazon im Meerschweinchenherzen. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.263, 417 (1969).
Jalling, O., Lindberg, O., Ernster, L.: On the effect of substituted barbiturates on mitochondrial respiration. Acta chem. scand.9, 198 (1955).
Kahl, G.-F.: Zur Wirkung von Metyrapon auf ElektronentransportvorgÄnge in der Leberzelle. Naunyn-Schmiedebergs Arch. Pharmak.264, 251 (1969).
Kahl, G. F.: Experiments on the metyrapone reducing microsomal enzyme system. Naunyn-Schmiedebergs Arch. Pharmak.266, 61 (1970).
—, Netter, K. J.: The effect of metyrapone on cellular respiration and microsomal drug oxidation. Biochem. Pharmacol.19, 27 (1970).
Klingenberg, M., HÄfen, H. von: Wege des Wasserstoffs in Mitochondrien. I. Die Wasserstoffübertragung von Succinat zu Acetoacetat. Biochem. Z.337, 120 (1963).
Krebs, H. A.: Gluconeogenesis and redox state. Hoppe-Seylers Z. physiol. Chem.351, 288 (1970).
Leibman, K. C.: Effects of metyrapone on liver microsomal drug oxidations. Fed. Proc.25, 417 (1966).
—: Effects of metyrapone on liver microsomal drug oxidations. Molec. Pharmacol.5, 1 (1969).
Liddle, G. W., Island, D., Ester, H., Tomkins, G. M.: Modification of adrenal steroid patterns in man by means of an inhibitor of 11-Β-hydroxylase. J. clin. Invest.37, 912 (1958).
Lineweaver, H., Burk, D.: The determination of enzyme dissociation constants. J. Amer. chem. Soc.56, 658 (1934).
Ljunggren, G.: The preparation of acetoacetic solutions. Biochem. Z.145, 422 (1924).
Magalhâes, M. C., Magalhâes, M. M.: A stereologic study of the effects of metopiron on the rat adrenal. Lab. Invest.21, 491 (1969).
Miller, L. L., Bly, C. G., Watson, M. L., Bale, W. F.: The dominant role of the liver in plasma protein synthesis; a direct study of the isolated perfused rat liver with the aid of lysine-ɛC14. J. exp. Med.94, 431 (1951).
Netter, K. J., Jenner, S., Kajuschke, K.: über die Wirkung von Metyrapon auf den mikrosomalen Arzneimittelabbau. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path.259, 1 (1967).
—, Kahl, G.-F., Magnussen, M. P.: Kinetic experiments on the binding of metyrapone to liver microsomes. Naunyn-Schmiedebergs Arch. Pharmak.265, 205 (1969).
Pressman, B. C.: Oxidative phosphorylation with ferricyanide as terminal electron acceptor. Biochim. biophys. Acta (Amst.)17, 273 (1955).
Pumphrey, A. M., Redfearn, E. R.: Inhibition of succinate oxidation by barbiturates in tightly coupled mitochondria. Biochim. biophys. Acta (Amst.)74, 317 (1963).
Salway, J. G.: The simultaneous determination of acetoacetate and glucose in capillary blood. Clin. chim. Acta25, 109 (1969).
Sanzari, N. P., Péron, F. G.: Influence of metopirone on substrate-supported hydroxylation of DOC by rat adrenal mitochondria. Steroids8, 929 (1966).
Sehimassek, H.: Perfusion of isolated rat liver with a semisynthetic medium and control of liver function. Life Sci.11, 629 (1962).
Simon, S., Kahl, G. F., Netter, K. J.: Beeinflussung von Redoxstatus und Sauerstoffverbrauch isoliert perfundierter Rattenlebern durch Metyrapon. Naunyn-Schmiedebergs Arch. Pharmak.266, 454 (1970).
Sprunt, J. G., Browning, M. C. K., Hannah, D. M.: Some aspects of the pharmacology of metyrapone. Mem. Soc. Endocr.17, 193 (1967).
Sweat, M. L., Young, R. B., Bryson, M. J.: Studies of the oxidation state of partially purified adrenal cortex mitochondrial cytochrome P-450 and difference spectra induced by deoxycorticosterone and metopirone. Arch. Biochem.130, 66 (1969).
Szeberényi, Sz., Szalay, K. Sz., Garattini, S.: Daily rhythm of metyrapone metabolism in rats. Biochem. Pharmacol.18, 2767 (1969).
Wertb, G., Boiteux, A.: Zur Toxikologie der Triphenylmethanfarbstoffe. Malachitgrün als Entkoppler der oxydativen Phosphorylierung in vivo und in vitro. Arch. Toxikol.23, 82 (1968).
Williamson, D. H., Lund, P., Krebs, H. A.: The redox state of free nicotinamideadenine dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem. J.103, 514 (1967).
—, Mellanby, J., Krebs, H. A.: Enzymic determination of D(−)-Β-hydroxybutyric acid and acetoacetic acid in blood. Biochem. J.82, 90 (1962).
Author information
Authors and Affiliations
Additional information
The experiments were carried out with the financial support of the Deutsche Forschungsgemeinschaft. Some of the equipment was provided by the Stiftung Volkswagenwerk.
We thank Professor Dr. W. Staib, Düsseldorf, for the demonstration of his liver perfusion technique.
The able and careful technical assistance of Miss Ingeborg Raab is gratefully acknowledged.
Rights and permissions
About this article
Cite this article
Kahl, G.F., Simon, S. Action of metyrapone on the redox state of free nicotinamide-adenine dinucleotide and on oxygen consumption of perfused rat livers and isolated mitochondria. Naunyn-Schmiedebergs Arch. Pharmak. 268, 1–16 (1971). https://doi.org/10.1007/BF00997168
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00997168
Key-Words
- Metyrapone
- Inhibition of Mitochondrial Respiration
- Isolated Rat Liver
- Redox State of Pyridine Nucleotides